use of monosialogangliosid gml or of n - acetyl - - the other ingredients are lyso gml for prevention or reversal of long-term treatment with l-dopa in the therapy of parkinson's disease induced byn neural degeneration

摘要

The present invention refers to the use of ganglioside GM1 or the derivative thereof, the N-dichloroacetyl lyso GM1 (LIGA 20) for preventing or reversing neuronal degeneration induced by a long term treatment with L-DOPA in the therapy of Parkinson's disease.